Meatly concludes trials of its cultivated chicken product

London-based Meatly, which recently became the first company in the world to get authorization to sell cultivated pet food, has announced the successful conclusion of its feeding trials for Meatly Chicken.

The results indicated a consistent preference for Meatly Chicken, as 75% of owners reported their pets enjoying the cultivated meat more than their regular diets.

Three-fourths (75%) of the surveyed dogs ate their meals immediately or within the first few seconds of it being presented to them, while half (50%) continued licking their bowls after finishing their meal.

Methodology

Conducted by the scientist and veterinarian-led animal research company Treat Therapeutics, the trials involved a sample group of 31 privately owned dogs spanning 14 breeds across the UK.

The dogs were observed over 2 distinct periods: a single-day test in which they were fed Meatly Chicken for both meals of the day and a 2-week controlled trial comparing dogs fed on Meatly to those on a plant-based placebo diet.

“These results demonstrate that we can feed our pets truly sustainable and kinder meat without compromising on taste or nutritional values,” says CEO Owen Ensor.

Next steps

In addition to the results, Meatly recently completed a funding round to support its upcoming product launch. British pet retailer Pets at Home is among the investors, as is new backing from venture capital firms DSM-Firmenich Venturing, JamJar and Joyful Ventures.

Meatly says that this latest development will help support its plans to launch alongside its first brand partner in the first quarter of 2025.

“We aim to have a dog treat product. The commercials are figured out at the moment, but it will be small-scale with an industry partner, which will help give the consumer a taste for the future of pet food,” a company spokesperson tells GlobalPETS.

Meatly is also eying regulatory approval in the US, Canada and the European Union to broaden its market reach in the dog food industry.